LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions

Cancer statistics, 2014

Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Adaptive Response of Human Lymphocytes to Low Concentrations of Radioactive Thymidine

Gregorio Olivieri, Judy Bodycote, Sheldon Wolff · Science · 1984 · 826 citations

Medicine, Immunology, Radiation Biophysics +11

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells

Katherine V. Ferry, Thomas C. Hamilton, Steven W. Johnson · Biochemical Pharmacology · 2000 · 275 citations

Medicine, Molecular Biology, Oncology +14

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer

Philipp Harter, Z Muallem, Dietmar Lorenz et al. · Gynecologic Oncology · 2011 · 198 citations

Medicine, Quality Management, Surgery +16

Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells

Amit Kumar Srivastava, Chunhua Han, Ran Zhao et al. · Proceedings of the National Academy of Sciences · 2015 · 183 citations · Full text

Medicine, Cancer Biology, Oncology +17